| |
|
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >> |
| |
Carefusion Paying $3.3 Million For Fraud Charges
[5281 Words]
[ Price : $8.95]
|
| The Justice Department says Carefusion is paying $3.3 million to resolve False Claims Act charges that it bought and sold uncleared and unapproved medical devices. |
|
05/16/2019
|
| |
|
|
|
| |
|
FDA OK’s Combo Drugs for Kidney Cancer
[200 Words]
[ Price : $8.95]
|
| FDA approves an EMD Serono and Pfizer NDA for Bavencio (avelumab) in combination with Pfizer’s Inlyta (axitinib) for the first-line treatment of patients with advanced renal cell carcinoma. |
|
05/16/2019
|
| |
|
| |
|
Pfizer sNDA Approved for Pediatric-use Fragmin
[312 Words]
[ Price : $8.95]
|
| FDA approves a Pfizer sNDA for Fragmin (dalteparin sodium) subcutaneous injection to reduce the recurrence of symptomatic venous thromboembolism in pediatric patients aged one month and older. |
|
05/16/2019
|
| |
|
| |
|
Ethicon Recalls Endo-Surgery Intraluminal Staplers
[204 Words]
[ Price : $8.95]
|
| Ethicon recalls its Endo-Surgery Curved Intraluminal Stapler with Adjustable Height Staples and Endo-Surgery Endoscopic Curved Intraluminal Stapler with Adjustable Height Staples due to insufficient firing. |
|
05/16/2019
|
| |
|
| |
|
Drug Development Landscape Evolving
[2698 Words]
[ Price : $8.95]
|
| Iqvia Institute identifies and analyzes trends in drug research and development in the next five years. |
|
05/16/2019
|
| |
|
| |
|
FDA Part of Generic Drug Bioinformatics Research
[2792 Words]
[ Price : $8.95]
|
| University of Florida and Office of Generic Drugs researchers are developing a bioinformatics approach to evaluating bioinequivalence reports on generic drugs. |
|
05/16/2019
|
| |
|
|
|
| |
|
FDA Clears GenePOC Carba Assay
[164 Words]
[ Price : $8.95]
|
| FDA clears a GenePOC 510(k) for the Carba assay and its use with the Revogene device to detect carbapenem-producing organisms. |
|
05/16/2019
|
| |
|
| |
|
CMS Ad Drug Price Rule Questioned
[2837 Words]
[ Price : $8.95]
|
| Forbes says a proposed CMS rule requiring drug companies to include the list price of most prescription drugs in their TV ads is likely to confuse consumers more than it helps them. |
|
05/16/2019
|
| |
|
| |
|
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >> |
| |
RSS
